What 7 Analyst Ratings Have To Say About Cedar Fair
Cedar Fair (NYSE:FUN) has observed the following analyst ratings within the last quarter:
Rosenblatt Maintains Neutral on Cedar Fair, Raises Price Target to $41
Rosenblatt analyst Barton Crockett maintains Cedar Fair (NYSE:FUN) with a Neutral and raises the price target from $40 to $41.
Rosenblatt Maintains Neutral on Cedar Fair, Lowers Price Target to $40
Rosenblatt analyst Barton Crockett maintains Cedar Fair (NYSE:FUN) with a Neutral and lowers the price target from $51 to $40.
Expert Ratings for Cedar Fair
Within the last quarter, Cedar Fair (NYSE:FUN) has observed the following analyst ratings:
Citigroup Maintains Buy on Cedar Fair, Lowers Price Target to $55
Citigroup analyst James Hardiman maintains Cedar Fair (NYSE:FUN) with a Buy and lowers the price target from $67 to $55.
B. Riley Securities Maintains Buy on Cedar Fair, Lowers Price Target to $68
B. Riley Securities analyst Eric Wold maintains Cedar Fair (NYSE:FUN) with a Buy and lowers the price target from $80 to $68.
10 Consumer Discretionary Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Where Cedar Fair Stands With Analysts
Cedar Fair (NYSE:FUN) has observed the following analyst ratings within the last quarter:
Read How Cedar Fair Fared In Q1
Cedar Fair L.P. (NYSE:FUN) reported first-quarter FY22 revenues of $98.8 million, beating the consensus of $76.93 million. During 1Q22, the…
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.